Northern Trust Corp Harvard Bioscience Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Northern Trust Corp holds 452,036 shares of HBIO stock, worth $967,357. This represents 0.0% of its overall portfolio holdings.

Number of Shares
452,036
Previous 448,622 0.76%
Holding current value
$967,357
Previous $1.28 Million 4.93%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$2.64 - $3.54 $9,012 - $12,085
3,414 Added 0.76%
452,036 $1.22 Million
Q2 2024

Aug 14, 2024
SELL
$2.77 - $4.63 $20,705 - $34,609
-7,475 Reduced 1.64%
448,622 $1.28 Million
Q1 2024

May 14, 2024
SELL
$4.02 - $5.39 $46,435 - $62,259
-11,551 Reduced 2.47%
456,097 $1.93 Million
Q4 2023

Feb 13, 2024
BUY
$4.0 - $5.49 $3,760 - $5,160
940 Added 0.2%
467,648 $2.5 Million
Q3 2023

Nov 13, 2023
BUY
$4.0 - $5.82 $21,224 - $30,880
5,306 Added 1.15%
466,708 $2.01 Million
Q2 2023

Aug 11, 2023
BUY
$4.19 - $6.16 $1.13 Million - $1.66 Million
269,103 Added 139.94%
461,402 $2.53 Million
Q1 2023

May 15, 2023
BUY
$2.45 - $4.22 $3,388 - $5,836
1,383 Added 0.72%
192,299 $807,000
Q4 2022

Feb 13, 2023
SELL
$2.12 - $2.86 $1,333 - $1,798
-629 Reduced 0.33%
190,916 $528,000
Q3 2022

Nov 14, 2022
SELL
$2.33 - $3.92 $984,588 - $1.66 Million
-422,570 Reduced 68.81%
191,545 $490,000
Q2 2022

Aug 12, 2022
BUY
$3.28 - $6.42 $517,029 - $1.01 Million
157,631 Added 34.53%
614,115 $2.21 Million
Q1 2022

May 13, 2022
SELL
$5.16 - $7.14 $122,591 - $169,632
-23,758 Reduced 4.95%
456,484 $2.83 Million
Q4 2021

Feb 08, 2022
SELL
$6.37 - $8.18 $61,470 - $78,937
-9,650 Reduced 1.97%
480,242 $3.39 Million
Q3 2021

Nov 15, 2021
SELL
$6.98 - $8.47 $57,626 - $69,928
-8,256 Reduced 1.66%
489,892 $3.42 Million
Q2 2021

Aug 13, 2021
BUY
$5.44 - $8.4 $79,810 - $123,236
14,671 Added 3.03%
498,148 $4.15 Million
Q1 2021

May 12, 2021
SELL
$3.91 - $6.99 $522,008 - $933,206
-133,506 Reduced 21.64%
483,477 $2.64 Million
Q4 2020

Feb 11, 2021
SELL
$3.0 - $4.5 $77,301 - $115,951
-25,767 Reduced 4.01%
616,983 $2.65 Million
Q3 2020

Nov 16, 2020
BUY
$2.75 - $4.2 $714,892 - $1.09 Million
259,961 Added 67.91%
642,750 $1.94 Million
Q2 2020

Aug 14, 2020
BUY
$2.12 - $3.14 $474,873 - $703,350
223,997 Added 141.06%
382,789 $1.19 Million
Q1 2020

May 14, 2020
BUY
$1.42 - $3.29 $1,770 - $4,102
1,247 Added 0.79%
158,792 $350,000
Q4 2019

Feb 14, 2020
SELL
$2.45 - $3.25 $2,205 - $2,925
-900 Reduced 0.57%
157,545 $480,000
Q3 2019

Nov 13, 2019
SELL
$1.59 - $3.47 $429,139 - $936,549
-269,899 Reduced 63.01%
158,445 $487,000
Q2 2019

Aug 13, 2019
SELL
$1.93 - $4.59 $33,554 - $79,801
-17,386 Reduced 3.9%
428,344 $857,000
Q1 2019

May 13, 2019
BUY
$2.77 - $4.38 $6,941 - $10,976
2,506 Added 0.57%
445,730 $1.92 Million
Q4 2018

Feb 12, 2019
BUY
$3.03 - $5.0 $3,133 - $5,170
1,034 Added 0.23%
443,224 $1.41 Million
Q3 2018

Nov 14, 2018
BUY
$5.0 - $6.65 $255,180 - $339,389
51,036 Added 13.05%
442,190 $2.32 Million
Q2 2018

Aug 14, 2018
BUY
$4.2 - $5.95 $1.27 Million - $1.8 Million
302,184 Added 339.65%
391,154 $2.09 Million
Q1 2018

May 09, 2018
SELL
$3.3 - $5.15 $5,448 - $8,502
-1,651 Reduced 1.82%
88,970 $445,000
Q4 2017

Feb 14, 2018
BUY
$3.08 - $3.8 $16,065 - $19,820
5,216 Added 6.11%
90,621 $299,000
Q3 2017

Nov 13, 2017
BUY
$2.7 - $3.75 $230,593 - $320,268
85,405
85,405 $320,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email